1. Home
  2. SAMG vs ACOG Comparison

SAMG vs ACOG Comparison

Compare SAMG & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$14.47

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.80

Market Cap

130.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
ACOG
Founded
2002
2000
Country
United States
Canada
Employees
164
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
130.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
SAMG
ACOG
Price
$14.47
$5.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
31.8K
94.3K
Earning Date
10-30-2025
11-13-2025
Dividend Yield
6.15%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$125,322,000.00
$7,427,199.00
Revenue This Year
$4.23
N/A
Revenue Next Year
$7.48
$101.16
P/E Ratio
$18.99
N/A
Revenue Growth
4.23
N/A
52 Week Low
$13.23
$3.75
52 Week High
$19.20
$11.54

Technical Indicators

Market Signals
Indicator
SAMG
ACOG
Relative Strength Index (RSI) 60.06 39.10
Support Level $13.32 $5.66
Resistance Level $13.79 $6.18
Average True Range (ATR) 0.38 0.44
MACD 0.12 0.03
Stochastic Oscillator 100.00 20.62

Price Performance

Historical Comparison
SAMG
ACOG

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: